Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 45.60
-1.90 (-4.00%)
Sep 30, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 2.17 billion as of September 29, 2026. Its market cap has increased by 36.89% in one year.
Market Cap
2.17B
Enterprise Value
2.57B
Revenue
650.87M
Ranking
n/a
PE Ratio
31.46
Stock Price
45.60
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 2.17B, an increase of 183.13%. That is a compound annual growth rate of 5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 2.17B | 53.23% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 4.00B |
| Easywell Biomedicals | 3.54B |
| Maywufa Company | 2.77B |
| Allied Biotech | 2.75B |
| Merdury Biopharmaceutical | 2.45B |
| PhytoHealth | 2.25B |
| Johnson Chemical Pharmaceutical Works | 2.15B |
| TSH Biopharm Corporation | 1.94B |